ProstaLund
1.095 SEK +1.39%Be the first to follow this company
ProstaLund operates in medical technology. Today, specialisation is mainly in the area of treatment of benign prostate enlargement (BPH). Through the company CoreTherm, heat treatment of benign prostate enlargement is offered, without the need for surgical operation. The vision is to offer both faster and more efficient solutions against traditional forms of infestation. The company was founded in 1991 and is operating globally, based in Lund.
Revenue
22.21M
EBIT %
-75.87 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
PLUN
Daily low / high price
1.07 / 1.095
SEK
Market cap
83.86M SEK
Turnover
85.71K SEK
Volume
79K
Financial calendar
Interim report
16.05.2024
General meeting
30.05.2024
Interim report
19.08.2024
Interim report
07.11.2024
Annual report
20.02.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Mats Alyhr | 20.5 % | 20.5 % |
BFCM P/C BFCM Sweden Retail LT | 8.8 % | 8.8 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Two new studies with ProstaLund´s Schelin Catheter® presented at EAU24 in Paris
Schelin Catheter® - new study confirms efficiency and ease of use
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools